相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Silymarin Inhibits Cytokine-Stimulated Pancreatic Beta Cells by Blocking the ERK1/2 Pathway
Eun Jeong Kim et al.
BIOMOLECULES & THERAPEUTICS (2014)
Molecular mechanisms linking neuroinflammation and neurodegeneration in MS
Erik Ellwardt et al.
EXPERIMENTAL NEUROLOGY (2014)
Beta Interferon Regulation of Glucose Metabolism Is PI3K/Akt Dependent and Important for Antiviral Activity against Coxsackievirus B3
J. D. Burke et al.
JOURNAL OF VIROLOGY (2014)
Silymarin Inhibits Cell Cycle Progression and mTOR Activity in Activated Human T Cells: Therapeutic Implications for Autoimmune Diseases
Marjan Gharagozloo et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2013)
Immunosuppressive Effect of Silymarin on Mitogen-Activated Protein Kinase Signalling Pathway: the Impact on T Cell Proliferation and Cytokine Production
Marjan Gharagozloo et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2013)
The Transcription Factor T-bet Is Induced by Multiple Pathways and Prevents an Endogenous Th2 Cell Program during Th1 Cell Responses
Jinfang Zhu et al.
IMMUNITY (2012)
Th1 versus Th17: Are T cell cytokines relevant in multiple sclerosis?
Amy E. Lovett-Racke et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
T cells in multiple sclerosis and experimental autoimmune encephalomyelitis
J. M. Fletcher et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Silymarin Inhibits In Vitro T-Cell Proliferation and Cytokine Production in Hepatitis C Virus Infection
Chihiro Morishima et al.
GASTROENTEROLOGY (2010)
Discrete Roles of STAT4 and STAT6 Transcription Factors in Tuning Epigenetic Modifications and Transcription during T Helper Cell Differentiation
Lai Wei et al.
IMMUNITY (2010)
Downregulation of nuclear factor-kappa B (NF-κB) pathway by silibinin in human monocytes challenged with Paracoccidioides brasiliensis
Camila Ferreira Bannwart et al.
LIFE SCIENCES (2010)
Silymarin suppress CD4+T cell activation and proliferation: Effects on NF-κB activity and IL-2 production
Marjan Gharagozloo et al.
PHARMACOLOGICAL RESEARCH (2010)
Silibinin Suppresses TNF-α-Induced MMP-9 Expression in Gastric Cancer Cells through Inhibition of the MAPK Pathway
Sangmin Kim et al.
MOLECULES (2009)
Silibinin inhibits hypoxia-inducible factor-1α and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy
P. Garcia-Maceira et al.
ONCOGENE (2009)
The multiple facets of mTOR in immunity
Thomas Weichhart et al.
TRENDS IN IMMUNOLOGY (2009)
Immunoregulatory functions of mTOR inhibition
Angus W. Thomson et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Signal Transducer and Activator of Transcription 4 Is Required for the Transcription Factor T-bet to Promote T Helper 1 Cell-Fate Determination
Vivian T. Thieu et al.
IMMUNITY (2008)
Silibinin inhibits cytokine-induced signaling cascades and down-regulates inducible nitric oxide synthase in human lung carcinoma A549 cells
Manesh Chittezhath et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Differential diagnosis of suspected multiple sclerosis: a consensus approach
D. H. Miller et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
STAT nuclear translocation: potential for pharmacological intervention
Thomas Meyer et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
Hania Kebir et al.
NATURE MEDICINE (2007)
Activation of the signal transducers and activators of the transcription 3 pathway in alveolar epithelial cells induces inflammation and adenocarcinomas in mouse lung
Yuan Li et al.
CANCER RESEARCH (2007)
Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells
Chapla Agarwal et al.
CARCINOGENESIS (2007)
Interferon-beta - Mechanism of action and dosing issues
Clyde E. Markowitz
NEUROLOGY (2007)
The role of STATs in lung carcinogenesis: an emerging target for novel therapeutics
Michalis V. Karamouzis et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
Silybin and silymarin - New and emerging applications in medicine
Radek Gazak et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Multiple sclerosis: a complicated picture of autoimmunity
Henry F. McFarland et al.
NATURE IMMUNOLOGY (2007)
MRI and the diagnosis of multiple sclerosis: expanding the concept of no better explanation
Arnaud Charil et al.
LANCET NEUROLOGY (2006)
Extracellular signal-regulated kinase is essential for interleukin-1-induced and nuclear factor κB-mediated gene expression in insulin-producing INS-1E cells
L Larsen et al.
DIABETOLOGIA (2005)
Protection against lipopolysaccharide-induced sepsis and inhibition of interleukin-1 beta and prostaglandin E2 synthesis by silymarin
JS Kang et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Interferon (IFN)-beta 1a and IFN-beta 1b block IFN-gamma-induced disintegration of endothelial junction integrity and barrier
A Minagar et al.
ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH (2003)
Silymarin protects dopaminergic neurons against lipopolysaccharide-induced neurotoxicity by inhibiting microglia activation
MJ Wang et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Critical role for STAT4 activation by type 1 interferons in the interferon-γ response to viral infection
KB Nguyen et al.
SCIENCE (2002)
T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells
M Afkarian et al.
NATURE IMMUNOLOGY (2002)
T-bet is rapidly induced by interferon-γ in lymphoid and myeloid cells
AA Lighvani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo
JR Grandis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)